Registered outcomes25

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

21 to 25 of 25

List	Outcome	Time frame
Primary	Time course of liver volume (assessed by CT or MRI) from initial dosing in the preceding study	Week 78, 104, an average of 52 weeks after Week 104, up to approximately 10.6 years
Primary	Time course of spleen volume (assessed by CT or MRI) from initial dosing in the preceding study	Week 78, 104, an average of 52 weeks after Week 104, up to approximately 10.6 years
Primary	Time course of cardiac function (assessed by echocardiography) from initial dosing in the preceding study	Week 78, 104, an average of 52 weeks after Week 104, up to approximately 10.6 years
Primary	Time course of 6-minute walk test distance from initial dosing in the preceding study	Week 104, an average of 52 weeks after Week 104, up to approximately 10.6 years
Primary	Time course of joint range of motion from initial dosing in the preceding study	Week 104, an average of 52 weeks after Week 104, up to approximately 10.6 years

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04348136/registered?page=2